The report presents a review of the evaluation of environmental risks posed by human pharmaceuticals.
Ref: ISBN 1857054113, LIT 1190 PDF, 489KB, 114 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
Reviews the information available in the literature on human pharmaceuticals in the environment, their occurrence, fate and effects, to highlight any gaps in knowledge and to recommend future actions, if required. Contacts were also made with research groups active in the field and consultation with the Association of the British Pharmaceutical Industry (ABPI) and the Proprietary Association of Great Britain (PAGB) was an integral part of the process. No detailed consideration was given to veterinary drugs due to significant differences in their nature, use and pathways to the environment. Nonetheless, the Environment Agency views the potential impact of veterinary drugs on the environment to be an important issue. In addition, no assessment was made of possible impacts on human health through drinking water as this falls outside the direct remit of the Environment Agency.